Singapore markets closed

Straits Times Index
3,272.72
+47.55(+1.47%)
S&P 500
5,010.60
+43.37(+0.87%)
Dow
38,239.98
+253.58(+0.67%)
Nasdaq
15,451.31
+169.30(+1.11%)
Bitcoin USD
66,095.56
+46.60(+0.07%)
CMC Crypto 200
1,421.82
+7.06(+0.50%)

Propanc Biopharma, Inc. (PPCB)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0011

0.0000

(0.00%)

At close: 03:57PM EDT

Trade prices are not sourced from all markets

All

Business Wire
Propanc Biopharma Receives Certificate of Grant for "Composition of Proenzymes for Cancer Treatment" Patent from European Patent Office
MELBOURNE, Australia, April 16, 2024--The PRP dosing patent is an important part of our IP portfolio, as we seek to protect our novel invention and create future value for our shareholders
Business Wire
Propanc Biopharma’s CEO Shares Views on Revolutionizing Cancer Treatment: An Inside Look at Drug Development & Strategic Financing
MELBOURNE, Australia, April 08, 2024--Mr. Nathanielsz appeared on a show with Mr. Joel Block, a weekly podcast on killer business strategies and how the best leaders make them work
Business Wire
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study
MELBOURNE, Australia, February 22, 2024--The compassionate use study results highlight clinical effects studied in 46 patients with advanced metastatic cancers of different origin